ipamorelin water retention side effect Effects: complete guide to safety, risks, and management CJC-1295 Ipamorelin: Benefits, Dosage &

BPC-157 Sermorelin CJC-1295 at a glance Sermorelin GH axis stimulant Binds pituitary GHRH receptors Stimulates endogenous GH release Most established evidence Compoundable with Rx CJC-1295 Extended GHRH analog Longer half-life than Sermorelin Often paired with Ipamorelin Small human trials only Regulatory status less clear BPC-157 Tissue repair peptide Gastric protein fragment Not GH axis Extensive animal data, minimal human trials Not FDA-approved or legally compoundable in US Fig

Vienna: Springer-Verlag Wien

The reasoning is that your GLP-1 receptor tolerance from semaglutide means the GLP-1 component of tirzepatide will not overwhelm your system, and the GIP component alone is unlikely to cause severe side effects at this dose

doi: 10.1002/lt.22178 [DOI] [PubMed] [Google Scholar] 178